<SUBMISSION>
<ACCESSION-NUMBER>0000943440-04-000137
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20040316
<ITEMS>5
<ITEMS>7
<FILING-DATE>20040318
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PETMED EXPRESS INC
<CIK>0001040130
<ASSIGNED-SIC>5912
<IRS-NUMBER>650680967
<STATE-OF-INCORPORATION>FL
<FISCAL-YEAR-END>0330
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-28827
<FILM-NUMBER>04677115
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1441 SW 29 AVENUE
<CITY>POMPANO BEACH
<STATE>FL
<ZIP>33069
<PHONE>9549794788
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1441 SW 29 AVENUE
<CITY>POMPANO BEACH
<STATE>FL
<ZIP>33069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k-316.txt
<TEXT>

=========================================================================

                               UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549




                                FORM 8-K



                              CURRENT REPORT

   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported): March 16, 2004



                            PETMED EXPRESS, INC.
          ------------------------------------------------------
          (Exact name of registrant as specified in its charter)



      FLORIDA                  000-28827                65-0680967
 -----------------         ----------------         -------------------
  (State or other          (Commission File           (IRS Employer
    jurisdiction                Number)             Identification No.)
 of incorporation)

1441 S.W. 29th Avenue, Pompano Beach, Florida              33069
---------------------------------------------       -------------------
  (Address of principal executive offices)               (Zip Code)




  Registrant's telephone number, including area code:  (954) 979-5995
                                                     ------------------



                             Not Applicable
     -------------------------------------------------------------
     (Former name or former address, if changed since last report)


<PAGE>


Item 5.   Other Events


On March 16, 2004, the PetMed Express, Inc. (the "Company")
Compensation Committee recommended that the Company's Board of
Directors amend the existing executive employment agreement (the
"agreement") of Menderes Akdag, the Company's Chief Executive
Officer.  The amendments were as follows: the term of the
agreement will be for three years,  commencing on March 16, 2004
(the "effective date"); Mr. Akdag's salary will be increased to
$250,000 per year throughout the term of the agreement, and Mr.
Akdag shall be granted 250,000 incentive stock options (the
"options") at an exercise price of $10.64 per share.  The options
will vest equally over a three year period in accordance with the
Company's 1998 Stock Option Plan.



Item 7.   Financial Statements and Exhibits

     (c)  Exhibits

Exhibit No.                    Description
-----------                    -----------


    99.1       Amendment No. 1 to Menderes Akdag's Executive
               Employment Agreement

    99.2       Menderes Akdag's Incentive Stock Option Agreement





<PAGE>


                           SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.

PETMED EXPRESS, INC.
(The "Registrant")



Date: March 16, 2004



By: /s/  Menderes Akdag
   -------------------------------
   Menderes Akdag

   Chief Executive Officer
   (principal executive officer)



By: /s/  Bruce S. Rosenbloom
   -------------------------------
   Bruce S. Rosenbloom


   Chief Financial Officer
   (principal financial and accounting officer)




<PAGE>


                          EXHIBIT INDEX


Exhibit No.                    Description
-----------                    -----------


    99.1       Amendment No. 1 to Menderes Akdag's Executive
               Employment Agreement

    99.2       Menderes Akdag's Incentive Stock Option Agreement




<PAGE>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>form8k316-ex991.txt
<TEXT>


                        EXHIBIT 99.1

AMENDMENT No. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT
-------------------------------------------------

     This  Amendment  No. 1 ("Amendment") to  the  Executive
Employment  Agreement ("Agreement") is entered  into  as  of
March  16, 2004 (the "Effective Date") by and between PetMed
Express,  Inc.  ("PetMed"  or the  "Company")  and  Menderes
Akdag, Chief Executive Officer of PetMed (the "Executive").

     WHEREAS,  PetMed  and the Executive  entered  into  the
Agreement dated March 16, 2001, and PetMed and the Executive
wish to amend the Agreement.

      NOW, THEREFORE, it is hereby agreed as follows:

     So  much  of Section 4 of the Agreement, Term as  reads
     "The Term of employment hereunder will commence on  the
     Effective  Date  as set forth above and  on  the  third
     anniversary  of the Effective Date." is hereby  revised
     to read "The Term of employment hereunder will commence
     on  the Effective Date as set forth above and will  end
     on the third anniversary of the Effective Date..."

      Section  5 of the Agreement, Compensation and Benefits
shall be revised as follows:

     * a.     Salary.  The  Executive  shall be  paid a base
       salary,  payable  in  accordance  with the  Company's
       policies from  time to  time for senior executives at
       an annual rate of Two Hundred Fifty  Thousand Dollars
       ($250,000.00).

     * b.     Options.    The  Executive  shall  be  granted
       250,000  incentive stock  options (the "Options")  to
       purchase shares of the  Company's Common Stock  at an
       exercise price equal to the  price of the stock as of
       the  close  of  business  on  March 16,  2004.   Such
       Options are granted  under the  Company's  1998 Stock
       Option Plan and are pursuant to the Option grant form
       attached  hereto  and  incorporated  herein  by  such
       reference.  The Options shall be exercisable from the
       date of  vesting  and  shall  vest,  subject  to  the
       continued  employment of  the  Executive,  (i) 83,333
       Options on the  first  anniversary  of the  Effective
       Date,  (ii) 83,333 Options  on the second anniversary
       of  the  Effective  Date,  and  (iii) 83,334  Options
       on the third anniversary of the Effective Date.

Except  as  expressly provided in this Amendment, all  other
terms,  conditions  and provisions of  the  Agreement  shall
continue in full force and effect as provided therein.

IN  WITNESS  WHEREOF, the parties hereto have duly  executed
this  Amendment  as  of  the date set  forth  in  the  first
paragraph of the Amendment.

                                  PetMed Express, Inc.

Witness  /s/ Alison Berges        By: /s/ Marc A. Puleo
       ------------------------      ----------------------
                                     Marc A. Puleo, M.D,
                                     President


Witness /s/ Bruce S. Rosenbloom   The Executive
       ------------------------
                                  /s/ Menderes Akdag
                                  -------------------------
                                  Menderes Akdag


                       99.1 page 1 - 1

<PAGE>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>form8k316-ex992.txt
<TEXT>

                        EXHIBIT 99.2

                    PetMed Express, Inc.
                     1441 SW 29th Avenue
                Pompano Beach, Florida  33069

March 16, 2004

Mendo Akdag
1441 SW 29th Avenue
Pompano Beach, Florida 33069

Dear Mendo:

      The  Board of Directors of PetMed Express, Inc. (the
"Corporation") is pleased to award you an Option pursuant to
the provisions of the PetMed Express, Inc. 1998 Stock Option
Plan (the  "Plan").  This letter will describe the Option
granted to you.  Attached to this letter is a copy of the
Plan.  The terms of the Plan also set forth provisions
governing the Plan.  Your signature on this letter is an
acknowledgment to us that you have read and understand the
Plan and that you agree to abide by its terms.  All terms
not defined in this letter shall have the same meaning as in
the Plan.

  1.   Type of Option.  You are granted an ISO.  Please see in
       --------------
       particular Section 11 of the Plan.

  2.   Rights and Privileges.   Subject to the conditions
       ---------------------
       hereinafter set forth, we grant you the right to purchase up
       to 250,000 shares of Stock at $10.64 per share, the current
       fair market value of a share of Stock. This option shall
       vest at the rate of 83,333 shares on each of the date
       hereof, March 16, 2005 and March 16, 2006 and 83,334 on
       March 16, 2007, providing that you have been continuously
       employed by the Corporation during such period.

  3.   Time of Exercise.  The Option may be exercised at any
       ----------------
       time and from time to time beginning when the right to
       purchase the shares of Stock accrues and ending when they
       terminate as provided in Section 5 of this letter.

  4.   Methods of Exercise.  The Options shall be exercised by
       -------------------
       written notice to the Chairman of the Board of Directors at
       the Corporation's principal place of business.  The notice
       shall set forth the number of shares of Stock to be acquired
       and shall contain a check payable to the Corporation in full
       payment for the Stock or that number of already owned shares
       of Stock equal in value to the total Exercise Price of the
       Option.  We shall make delivery of the shares of Stock
       subject to the conditions described in Section 13 of the
       Plan.

  5.   Termination of Option.  To the extent not exercised,
       ---------------------
       the Option shall terminate upon the first to occur of the
       following dates:


                       99.2 page 1 - 2

<PAGE>


       (a)  Three (3) years from the date of vesting pursuant to
the provisions of Section 2 of this Agreement; or

       (b)  The expiration of thirty (30) days following the date
your employment terminates with the Corporation and any of its
subsidiaries included in the Plan for any reason, other than by
reason of death or permanent disability.  As used herein,
"permanent disability" means your inability to engage in any
substantial gainful activity by reason of any medically
determinable physical or mental impairment which can be expected
to result in death or which has lasted or can be expected to last
for a continuous period of not less than 12 months; or

       (c)  The expiration of 12 months following the date your
employment terminates with the Corporation and any of its
subsidiaries included in the Plan, if such employment termination
occurs by reason of your death or by reason of your permanent
disability (as defined above).

  6.   Securities Laws.
       ---------------

       The Option and the shares of Stock underlying the Option
       have been registered under the Securities Act of 1933, as
       amended (the "Act").  The Option and the shares of Stock
       underlying the Option will remain registered, as long as
       the Company's reporting status with the Securities and
       Exchange Commission is current.  Such shares cannot be
       sold, transferred, assigned or otherwise hypothecated
       without registration under the Act or unless a valid
       exemption from registration is then available under
       applicable federal and state securities laws and the
       Corporation has been furnished with an option of counsel
       satisfactory in form and substance to the Corporation
       that such registration is not required.

  7.   Binding Effect.  The rights and obligations described
       --------------
       in this letter shall inure to the benefit of and be binding
       upon both of us, and our respective heirs, personal
       representatives, successors and assigns.

  8.   Date of Grant.  The Option shall be treated as having
       -------------
       been granted to you on the date of this letter even though
       you may sign it at a later date.

                               Very truly yours,


                               By:  /s/ Marc A. Puleo
                                  -------------------------------
                                  Marc A. Puleo, M.D, President


AGREED AND ACCEPTED:

/s/ Menderes Akdag
--------------------------


                       99.2 page 2 - 2

<PAGE>

</TEXT>
</DOCUMENT>
</SUBMISSION>
